MCC950, as an inhibitor of NLRP3, has been widely verified for the treatment of many inflammatory diseases, such as inflammatory bowel diseases,30 Parkinson's disease31 and Autoimmune encephalomyelitis,32 due to its low dose and minor side effects. The gene discussed is NLRP3; the disease is inflammatory bowel disease.